|Safe blood transfusion v. Window period
Mar 25, 2006
Hi Doc! I have heard that places that accept blood (for storage and transfusion) can know if the blood is infected even if the person donating is at his/her window period. Then why don't they use this technology to straight-away determine if a person is Hiv+ or not? My second question: After sustaining a severe hollow-bore needlestick and laceration while performing a medical procedure on a patient, were you on PEP? Thanks.
| Response from Dr. Frascino
The answer to your first question is a bit complex and technical, but I'll try to explain.
Blood donors have been screened for HIV since 1985. Although newer generations of the test have been developed that increase the sensitivity for detecting HIV antibodies, in rare instances infections in donors have been missed. In 2002 the FDA licensed the first NAT (nucleic acid test) for screening blood donors. NAT detects viral genes rather than anti-HIV antibodies or antigens (proteins from the virus). Viral gene detection allows for earlier detection, because the production of detectable antibodies, which is an immune response, requires time. With the use of NAT, the HIV window period has been reduced to approximately 16 days.
NAT is FDA-approved only for use in screening donated blood. It is not approved for routine HIV screening for individual patients. There are a number of reasons for this having to do with the sensitivity/specificity of the testing assay and the cost. The purpose of blood-donation screening is to protect the blood supply. Consequently the sensitivity of the screening tests is set so that it will err on the side of protecting the blood supply. In other words, if the test picks up some false positives, no problem. The questionably positive blood can then be discarded. Donors are notified to follow up with their doctors to see if their test was a false positive or if they are truly HIV infected. Again the primary purpose of these tests is not to diagnose patients, but to protect the blood supply. NAT is also extremely expensive. NAT testing is performed on pooled samples. That means usually around 20 donor samples are mixed together and tested as a batch. If the batch tests positive, then each of the 20 donor samples is tested individually by our usual serological testing methods. See, I told you this was a bit confusing.
As for your second question, my occupational exposure was in January 1991. We didn't know much about PEP back then and only a few antiretrovirals were even available. I did take AZT within moments of being stuck and continued it for a full course, but seroconverted nonetheless. The patient I was performing the procedure on had advanced-stage AIDS; consequently, his viral strain was probably resistant to AZT. We didn't have resistance tests back then. I should also point out that PEP, even when taken as directed, isn't always successful in preventing HIV infection.
Get Email Notifications When This Forum Updates or Subscribe With RSS
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.